Viewing Study NCT02051751


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-06 @ 4:39 PM
Study NCT ID: NCT02051751
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2014-01-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Breast Neoplasms, Head and Neck Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumors, Head and neck non squamous cell carcinoma, breast … View